NCT06530563View on ClinicalTrials.gov

the Efficacy and Safety of Oliceridine Fumarate Injection for Acute Pain After Abdominal Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

606

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

May 31, 2026

Conditions
Acute PainOpioid Analgesic Adverse Reaction
Interventions
DRUG

Oliceridine Injection [Olinvyk]

"Oliceridine fumarate injection, specifications: 1mg/1mL, 2mg/2 mL, 10mg/10 mL; Stored in the dark, 15-30 ℃, not frozen; Jiangsu Nhwa pharmaceutical co., LTD. Production.~Dexmedetomidine, specifications: 200ug/2ml; Ondansetron, specifications: 8mg/4ml."

DRUG

Sufentanil Citrate

"Sufentanil Citrate injection, specification: 50 ug/ml, 1 ml; Avoid light seal; Yichang humanwell pharmaceutical co., LTD.~Dexmedetomidine, specifications: 200ug/2ml; Ondansetron, specifications: 8mg/4ml."

Trial Locations (1)

410000

Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
collaborator

Wu Jieping Medical Foundation

OTHER

lead

Xiangya Hospital of Central South University

OTHER